Norman O. Burns II, who has almost three decades of experience in leadership at historical attractions, will take the Conner Prairie position Jan. 27, the museum announced Monday morning.
Indianapolis-based Chondrial Therapeutics LLC has been accepted into a program run by the National Institutes of Health that will provide the drug company with services worth at least $5 million, the company estimates.
Indiana Chamber of Commerce CEO Kevin Brinegar said business leaders hoped the first-term Republican would use his State of the State address “to close the book on the … issue.”
Executives at Eli Lilly and Co. are telling investors the worst is behind the company and only good things await. But the drugmaker still has a few things to prove.
Park officials did not offer details about the new exhibit, which is set to open July 1, but the park previously disclosed plans to open an attraction featuring a four-story treehouse surrounded by five activity areas.
Strong sales of drugs for diabetes, cancer and animals helped the Indianapolis drugmaker overcome falling sales of older drugs for depression and osteoporosis, pushing up fourth-quarter sales and profit.
In 2015, attendance hit new highs in several categories and corporate donations shattered 2014 gift amounts with a $7.5 million grant from the Lilly Endowment Inc.
"Indiana's economic competitiveness and the Hoosier brand have potentially been compromised again," said Indiana Competes, a business coalition that includes Cummins Inc., Eli Lilly and Co. and the NCAA.
It took former WISH-TV Channel 8 General Manager Jeff White only one trip to VisionThree’s studio to convince him to take an ownership stake in the company and spearhead sales and product development for the firm full time.
Privately-held Biostorage Technologies Inc., which specializes in biological sample storage, has been purchased by a Massachusetts-based firm in one of central Indiana’s largest disclosed-price acquisitions of the past year.
The finalists announced Tuesday have a range of specialties, from saving the muskox in the Arctic tundra to using Galapagos penguins to measure environmental change.
Teva’s acquisition will make it the world’s largest maker of generic medicines, giving it greater negotiating power with governments and private-health insurers.
The Pacers are the only professional sports team that owes its survival to a telethon, and that strange story is being told between 6 p.m. and 7 p.m. Friday as part of ESPN’s “30 for 30” shorts series.
The Indiana Biosciences Research Institute, set up just three years ago, announced Wednesday morning that it has been awarded grants of $80 million from the Lilly Endowment and $20 million from the Eli Lilly and Co. Foundation.
Indiana securities regulators are investigating how JPMorgan handled investments inside trusts that benefited churches in the state, Bloomberg News reported. The inquiry follows a lawsuit filed in 2014 by Christ Church Cathedral, which alleged the bank mismanaged trusts endowed by Eli Lilly Jr.
